Condition
NASH - Nonalcoholic Steatohepatitis clinical trials and research
As of November 12, 2026, Find a Trial lists 7 NASH - Nonalcoholic Steatohepatitis clinical trials that are recruiting, at sites in 28 countries (most in United States (3), France (3), Italy (3)). By phase: Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 28Countries
Newest NASH - Nonalcoholic Steatohepatitis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Multiple under-the-skin injections of B1344 for adults with NAFLD and NASH | Phase 1 | Beijing, Beijing Municipality and 4 other locations | Recruiting | Aug 19, 2025 |
| Evaluating efruxifermin for patients with compensated cirrhosis due to NASH/MASH | Phase 3 | Birmingham, Alabama and 344 other locations | Recruiting | Jul 30, 2024 |
| A registry for studying Non-Alcoholic Fatty Liver Disease in Europe | — | Antwerp and 36 other locations | Recruiting | Jun 22, 2020 |
| Observational cohort for non-alcoholic fatty liver disease and related conditions | — | Roma, Rome/lazio/italy | Recruiting | May 1, 2020 |
| Understanding the connection between obesity and liver inflammation | — | Scottsdale, Arizona | Recruiting | Jan 18, 2020 |
| Non-Invasive Assessment of Liver Health in Patients with NASH | — | Chandler, Arizona and 6 other locations | Recruiting | Aug 13, 2019 |
| Evaluating bariatric surgery for treating severe liver disease in obese patients | — | Lille | Recruiting | Mar 21, 2018 |
All recruiting trials (7)
-
Multiple under-the-skin injections of B1344 for adults with NAFLD and NASH
This trial will test whether repeated subcutaneous injections of an experimental drug called B1344 are safe and affect liver fat and related measures in adults with NAFLD or NASH.
-
Evaluating efruxifermin for patients with compensated cirrhosis due to NASH/MASH
This study is testing a new medication called efruxifermin to see if it can improve liver health in people with compensated cirrhosis caused by NASH or MASH.
-
A registry for studying Non-Alcoholic Fatty Liver Disease in Europe
This study is collecting health information and samples from people with Non-Alcoholic Fatty Liver Disease to learn more about the disease and find better ways to track its progress.
-
Observational cohort for non-alcoholic fatty liver disease and related conditions
This study is trying to learn more about non-alcoholic fatty liver disease and its related conditions by looking at patients with different stages of the disease and comparing them to people with diabetes and obesity who don't have it.
-
Understanding the connection between obesity and liver inflammation
This study looks at how extra fat around the liver and inflammation in body fat affect liver health and insulin resistance in people with obesity, especially those having gastric bypass surgery.
-
Non-Invasive Assessment of Liver Health in Patients with NASH
This study is testing a new imaging method to see if it can accurately identify patients with Nonalcoholic Steatohepatitis (NASH) without needing a liver biopsy.
-
Evaluating bariatric surgery for treating severe liver disease in obese patients
This study is testing whether bariatric surgery can help obese patients with severe liver disease get better compared to standard medical treatment.
Related topics
Quick answers
How many NASH - Nonalcoholic Steatohepatitis clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 28 countries. The most sites are in United States (3 trials), France (3 trials), Italy (3 trials), Germany (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.